2004
DOI: 10.1016/j.brainres.2004.02.072
|View full text |Cite
|
Sign up to set email alerts
|

Bone marrow grafts restore cerebral blood flow and blood brain barrier in stroke rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
112
0

Year Published

2007
2007
2020
2020

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 156 publications
(115 citation statements)
references
References 59 publications
3
112
0
Order By: Relevance
“…Other mechanisms have been suggested to explain the action of transplanted MSCs, such as an elevated level of transforming growth factor-b (TGF-b) that helps to reduce the formation of scar tissue, and restoration of cerebral blood flow and the blood-brain barrier in models of traumatic brain injury 45 and stroke. 47 Most of these studies found a small number of cells expressing markers of neural lineage; however, many have proposed alternative explanations for their findings of functional recovery, either because they found no evidence of neural differentiation after transplantation, or because the cells were so few in number. In contrast, functional improvement was documented with MSCs previously exposed to a 'neuronal' induction medium which resulted in increased differentiation into a neuronal phenotype.…”
Section: Nonhuman Mscsmentioning
confidence: 99%
“…Other mechanisms have been suggested to explain the action of transplanted MSCs, such as an elevated level of transforming growth factor-b (TGF-b) that helps to reduce the formation of scar tissue, and restoration of cerebral blood flow and the blood-brain barrier in models of traumatic brain injury 45 and stroke. 47 Most of these studies found a small number of cells expressing markers of neural lineage; however, many have proposed alternative explanations for their findings of functional recovery, either because they found no evidence of neural differentiation after transplantation, or because the cells were so few in number. In contrast, functional improvement was documented with MSCs previously exposed to a 'neuronal' induction medium which resulted in increased differentiation into a neuronal phenotype.…”
Section: Nonhuman Mscsmentioning
confidence: 99%
“…This hypoperfusion resolved by 28 days after ischemia, which may be due to the establishment of collateral blood supply. More recently, laser Doppler flowmetry has shown that periinfarct hypoperfusion prevails for several weeks after permanent (Eve et al, 2009) and transient (Borlongan et al, 2004) middle cerebral artery occlusion in rats. Dynamic susceptibility contrast MRI has shown that hypoperfusion prevails for at least 3 days in the ipsilateral striatum (Rudin et al, 2001) and up to 14 days in the ipsilateral cortex (Lin et al, 2002).…”
Section: Hypoperfusion At the Acute Phase In The Cortex And Thalamus mentioning
confidence: 99%
“…The aged brain cell therapy is a promising therapeutic strategy to promote brain tissue repair. In this regard, researchers are focused to identify the best candidate for stem cell therapy in stroke like Mesenchymal Stem Cells (MSCs) or Neural Stem Cells (NSCs) [5][6][7][8]. Of crucial importance when defining a novel therapeutic approach is the knowledge of mechanisms underlying the observed effects and to sustain these as long as long is needed for effective recovery.…”
Section: Stem Cells Therapy For Cerebral Ischemia In Preclinical Studiesmentioning
confidence: 99%